Versatile strategy using vaccinia virus-capping enzyme to synthesize functional 5' cap-modified mRNAs

Area of Science:

• Biochemistry
• Molecular Biology
• RNA Therapeutics

Background:

• Messenger RNA (mRNA) is a crucial genetic carrier with applications expanding in various scientific fields.
• The 5' cap of mRNA is vital for its stability and translation, driving research into chemically modified caps to enhance mRNA functionality.
• Current methods for mRNA 5' cap modification are being explored to improve therapeutic and research applications.

Purpose of the Study:

• To develop an easy and efficient method for synthesizing 5' cap-modified messenger RNAs (mRNAs).
• To investigate the impact of various modified 5' cap analogs on mRNA translation efficiency.
• To explore the potential for conjugating chemical structures to modified mRNAs to further enhance their functionality.

Main Methods:

• Utilized a vaccinia virus-capping enzyme for the synthesis of modified mRNA 5' caps.
• Introduced a variety of guanosine triphosphate (GTP) analogs to the 5' end of RNA molecules.
• Generated and analyzed 5' cap-modified mRNAs with distinct translation levels.

Main Results:

• Demonstrated the enzyme's capability to introduce diverse GTP analogs, creating a range of 5' cap-modified mRNAs.
• Observed varying translation levels among the synthesized modified mRNAs.
• Identified specific modified mRNAs that exhibit improved translation efficiency.
• Showcased the successful conjugation of chemical structures to modified mRNAs, enhancing their functionality.

Conclusions:

• The developed method provides a versatile approach for generating 5' cap-modified mRNAs.
• These modified mRNAs show potential for improved translation efficiency and expanded functionality.
• The findings offer valuable tools for advancing RNA therapeutics and fundamental biological research.